MiMedx

Read more
Timothy R Wright's photo - CEO of MiMedx

CEO

Timothy R Wright

CEO Approval Rating

70/100

Founded:

2008

Status:

PublicIndependent CompanyOTCBBMDXG

MIMEDX TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Osiris Therapeutics is MiMedx's #1 rival. Osiris Therapeutics is a Private company that was founded in Columbia, Maryland in 1992. Like MiMedx, Osiris Therapeutics also works within the Health Care Equipment field. Osiris Therapeutics has 330 fewer employees vs. MiMedx.

Organogenesis is perceived as one of MiMedx's biggest rivals. Organogenesis was founded in 1985, and is headquartered in Canton, Massachusetts. Like MiMedx, Organogenesis also operates in the Health Care Equipment sector. Organogenesis generates $130.9M more revenue vs. MiMedx.

Integra Lifesciences is a top competitor of MiMedx. Integra Lifesciences is a Public company that was founded in 1989 in Princeton, New Jersey. Like MiMedx, Integra Lifesciences also operates in the Health Care Equipment space. Compared to MiMedx, Integra Lifesciences has 3,010 more employees.

MiMedx Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$248.2M

MiMedx's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 341.5M. Over the last four quarters, MiMedx's revenue has grown by 11.8%. Specifically, in Q1 2021's revenue was $60M; in Q4 2020, it was $68.5M; in Q3 2020, it was $64.3M; in Q2 2020, MiMedx's revenue was $53.6M.

MiMedx Acquisitions

No recent acquisitions found related to MiMedx

MiMedx Funding History

Since MiMedx was founded in 2008, it has participated in 7 rounds of funding. In total MiMedx has raised $143.2M. MiMedx's last funding round was on Jul 2020 for a total of $50.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Jul 2020
$50M

Hayfin

Debt - PPP (CARES Act)
Apr 2020
$10M
Debt
Jun 2019
$75M
Equity
Jan 2016
$4M
-
Equity
Nov 2010
$2.1M
-

Since MiMedx was founded in 2008, it has participated in 7 rounds of funding. In total MiMedx has raised $143.2M. MiMedx's last funding round was on Jul 2020 for a total of $50.0M

MiMedx Investments

No recent investments found related to MiMedx

MiMedx News

MiMedx Press Releases

Social Media

MiMedx Headquarters

1775 West Oak Commons Court NE

Marietta, Georgia30062

770-651-9100

Driving Directions »

Trending Companies

MiMedx Summary

ABOUT

Overview

MiMedx is a biopharmaceutical company that develops and commercializes placental tissue-based therapeutics for the treatment of skin burns and wounds. MiMedx was founded in 2008. MiMedx's headquarters is located in Marietta, Georgia, USA 30062. It has...

CEO

MiMedx's CEO, Timothy R Wright, currently has an approval rating of 70%. MiMedx's primary competitors are Osiris Therapeutics, Organogenesis & Integra Lifesciences.

Website

mimedx.com

Frequently Asked Questions about MiMedx

  1. When was MiMedx founded?

    MiMedx was founded in 2008
  2. Who is MiMedx's CEO?

    MiMedx's CEO is Timothy R Wright
  3. How much revenue does MiMedx generate?

    MiMedx generates $248.2M in revenue
  4. How much funding does MiMedx have?

    MiMedx has historically raised $143.2M in funding
  1. Where is MiMedx's headquarters?

    MiMedx's headquarters is in Marietta Georgia, USA
  2. How many employees does MiMedx have?

    MiMedx has 690 employees
  3. What sector does MiMedx operate in?

    MiMedx is in Health Care Equipment, Health Care Supplies
  4. Who are MiMedx's competitors?

    MiMedx's top competitors are Osiris Therapeutics, Organogenesis, Integra Lifesciences